VIVO Cannabis Inc. VVCIF

It's all in the MD&A.. just take a look once..

[JreBud]

Feel like some people forget how much info gets looked over in the MD&A ..after reading Sept 2020s version again reinforces why I'm so bullish even when the SP is getting manipulated. Below are a few of my favorite points. -VIV0's family of brands, each targeting a specific market segment, include Canna Farms, Beacon Medical", Fireside", Lumina"" and Harvest Medicine"". Canadian Bud Collection" a new brand directed at the popular value segment of the market, was introduced to capture market share in this high-demand segment of the market. The Company currently sells over 100 stock keeping units (SKUS) and has successfully launched several new product lines in 2020. -After the signing of an exclusive agreement with Vertosa Inc. (an infusion technology company based in Oakland, California), for Canadian production rights, Vertosa's equipment was installed at the Vanluven facility. VIVO successfully produced its first batch of active emulsions using this technology for the cannabis beverage market in 03 and concluded its first sale and shipment early in Q4. VIV0 continues to advance its product -VIVO's Australian business continues to rapidly advance. The record level of sales achieved in in Q2 2020 are expected to be repeated in Q4 2020 barring export permit delays with Health Canada. Australia's Therapeutics Goods Administrator (TGA) continues to report a record number of new patient approvals and triple digit growth in patient approvals year- over-year. VIVO remains well positioned to capitalize on this rapidly growing market. -VIVO continued to advance its European expansion strategy through its partnership with Linneo Health, a Spanish-based EU-GMP certified supplier of pharma-grade cannabis. VIVO's subsidiary, Beacon Medical Germany, is expecting final approval of Linneo product for import to Germany in late 2020. Lots more to get excited about, and let the pessimist and shorters say what the like, but 2021 will be monumental for the company. The fact you can buy in today less then the Public offering at a 10% discount seems comical. Buying now and holding long term never seemed so sensible. Cheers to the longs!